Basil Systems delivers an AI-powered SaaS platform transforming how pharma and MedTech companies manage regulatory, clinical, and product lifecycle strategy. By structuring the world's largest indexed database of regulatory, drug, device, and post-market data, Basil helps life sciences organizations accelerate development, reduce risk, and improve product performance. Trusted by industry leaders, Basil turns complex data into actionable insights that drive better decisions and better patient outcomes.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 04/29/25 | $11,500,000 | Venture |
Argosy Capital Golden Ventures  Hearst Ventures | undisclosed |
